Send Message
View as an RSS Feed
  • The Arena Conspiracy And DEA Scheduling  [View article]
    Thank you for your well written article.
    The only thing that I would add is that for the to DEA to respond to the 69 something comments submitted to them is that a decision has been reached by the DEA.
    Why not just respond in the FR to the general public who deserve an answer as much as the individuals who wrote the comments and at their leisure respond to the individuals??
    Apr 8, 2013. 09:16 AM | 1 Like Like |Link to Comment
  • Arena Pharmaceuticals: Risk Vs. Reward  [View article]
    Thank you for your informative article! The DEA has held up the launch of FDA APPROVED BELVIQ for 9 month. The FDA provided the DEA with all the scientific data and recommened scheduling yet here we are 9 months later waiting on scheduling approval. Just how long can you schuffle the same paper work??
    Mar 20, 2013. 05:20 PM | 8 Likes Like |Link to Comment
  • Arena Dips Below $8 - Uncertainty Is Key  [View article]
    The FDA did all the scientfic and technical work on Belviq. All the DEA had to do was read the fda report and schedule it. Taking 9 months to do this is absurd. Full investigation of the dea is called for.

    ps: I wonder how many people have died or contracted diabetes because of the DEA taking 9 months and counting to shuffle some paper work??????
    Mar 19, 2013. 11:34 AM | 1 Like Like |Link to Comment
  • Arena Breaking Out Ahead Of European Approval  [View article]
    Thank you for well thought out article. You did your homework and it really showed. You used the science to prove your article. The medical community and their patients are the true winners here. Thanks for spreading the word.
    Jan 9, 2013. 12:07 PM | 1 Like Like |Link to Comment
  • Yahoo (YHOO) is downgraded to Hold from Buy by Bernstein's Carlos Kirjner, who says it's hard to see the upside from here following a 6-month 33% rally. He notes the timing of the Alibaba IPO is uncertain and the core business may produce weaker-than-expected results in H1. Shares -1.6% premarket.  [View news story]
    over $ 3, 000 000 000 ( Billion ) in yhoo shares to be purchased by yahoo. This will up the anti.
    Jan 7, 2013. 12:49 PM | Likes Like |Link to Comment
  • Can A New Management Team Spur Growth In This Undervalued Tech Company?  [View article]
    well done - very informative
    Dec 31, 2012. 08:51 PM | Likes Like |Link to Comment
  • Key Dates For Arena And Orexigen Investors  [View article]

    Good article - well thought out and objective!
    Dec 26, 2012. 02:45 PM | Likes Like |Link to Comment
  • Obesity Sector Update And Compelling Short Opportunity  [View article]
    Don't quit your day job !
    Nov 12, 2012. 07:25 PM | 1 Like Like |Link to Comment
  • Now Could Be The Time To Speculate On Achillion Pharmaceuticals  [View article]
    good article on achn. But you don't have to be too observant to see that you tied arna to your story for the name recognition. Very few know of achn but millions have heard of arna and its future block buster drug. I would dare say that most of those who read your article did so because of the arna tie in.
    Oct 30, 2012. 03:14 PM | 2 Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Pipeline Overview And Stock Valuation  [View article]
    Pipeline Overview = good way to describe your excellent article! Obiviously avanir has a lot going on with " NUEDEXTA ". Future looks good for many long suffering patients with a variety of diseases.
    Thank you for helping to bring " NUEDEXTA " to the public's attention.
    Oct 25, 2012. 11:01 AM | 1 Like Like |Link to Comment
  • Near-Term Catalyst Could Drive ChromaDex Shares Higher  [View article]
    you could not have done any research on arna, you facts are all wrong. The tumor and rats and cardiovascular problem have long been proven to be false.
    Sep 14, 2012. 09:55 PM | 4 Likes Like |Link to Comment
  • Avanir: Congressional Inquiry Into the Pricing of Nuedexta Abandoned  [View article]
    your article closes the door on those who would discredit avnr and keep needed medication ( one of a kind) out of the hands of those who so desperatly need it.
    Thank you
    Jul 22, 2011. 11:09 AM | 2 Likes Like |Link to Comment
  • Avanir Pharmaceuticals' Possible and Unofficial Sales Guidance Is Good for Long-Term Investors  [View article]
    would like to see more testimonials published. Its not always about the money. There is a proven need for avnr's " neudexta".
    May 4, 2011. 02:03 PM | 2 Likes Like |Link to Comment
  • Contrarian Ideas: 12 Beaten Up Stocks Seeing Strong Buy Volume Accumulation  [View article]
    volume speaks volumes. Thanks!
    Mar 7, 2011. 09:49 AM | 1 Like Like |Link to Comment
  • Why Yahoo Can't Pay A Dividend  [View article]
    thanks, you nailed it!!!!!!!!!
    Sep 28, 2010. 12:37 PM | Likes Like |Link to Comment